Skip to main content
SpringerLink
Log in

Extracellular products of type IIIStreptococcus agalactiae and their relationship to virulence

  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

Various human isolates of type III group B streptococci (GBS) orStreptococcus agalactiae could be divided into two distinct groups (high and low producers) on the basis of their in vitro production of extracellular type-specific antigen (ETSA). The high ETSA producers were shown to be significantly more virulent in mice than were the low producers. In an effort to examine the possibility that purified extracellular products (ETSA, neuraminidase, or protease_ had a significant effect on GBS virulence in the mouse model, mice received either 1.0 ml of organisms intraperitoneally (IP) or 1.0 ml of organisms IP plus 0.1 ml IP of the appropriate purified extracellular products. Only purified ETSA demonstrated a substantial decrease (1.0 log10) in the 50% lethal dose (LD50) values and only for a high ETSA producing strain. Serum from mice infected with a high ETSA producer contained approximately 12.5 μg/ml of the ETSA, whereas serum from mice infected with a low ETSA producer contained no detectable ETSA. These data imply that the two different types of organisms (high and low ETSA producers) have somewhat different mechanisms of pathogenicity in the mouse model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literature Cited

  1. Baker, C. J., Barrett, F. F., Gordon, R. C., Yow, M. D. 1973. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. Journal of Pediatrics82:724–729.

    PubMed  Google Scholar 

  2. Baker, C. J., Webb, B. J., Jackson, C. V., Edwards, M. S. 1980. Counter-current immunoelectrophoresis in the evaluation of infants with group B streptococcal disease. Pediatrics65:1110–1114.

    PubMed  Google Scholar 

  3. Doran, T. I., Straus, D. C., Mattingly, S. J. 1980. Extracellular antigens of serotype III group B streptococci. Infection and Immunity30:890–893.

    PubMed  Google Scholar 

  4. Durham, D. L., Mattingly, S. J., Doran, T. I., Milligan, T. W., Straus, D. C. 1981. Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model. Infection and Immunity34:448–454.

    PubMed  Google Scholar 

  5. Edwards, M. S., Baker, C. J., Kasper, D. L. 1979. Opsonic specificity of human antibody to the type III polysaccharide of group B streptococcus. Journal of Infectious Diseases140:1004–1008.

    PubMed  Google Scholar 

  6. Farr, R. S. 1948. A quantitative immunochemical measure of the primary interaction between I*BSA and antibody. Journal of Infectious Diseases103:239–262.

    Google Scholar 

  7. Ferrieri, P., Gray, E. D., Wannamaker, L. W. 1980. Biochemical and immunological characterization of the extracellular nucleases of group B streptococci. Journal of Experimental Medicine151:56–68.

    PubMed  Google Scholar 

  8. Franciosi, R. A., Knostman, J. D., Simmerman, R. A. 1973. Group B streptococcal neonatal and infant infections. Journal of Pediatrics82:707–718.

    PubMed  Google Scholar 

  9. Gutschik, E., Motles, S., Christensen, N. 1979. Experimental endocarditis in rabbits. 3 Significance of proteolytic capability of the infecting strains ofStreptococcus faecalis. Acta Pathologica Microbiologica Scandanavia, Section B87:353–362.

    Google Scholar 

  10. Hastings, M. J. G., Easmon, C. S. F. 1981. Variations in the opsonic requirements of group B streptococcus type III. British Journal of Experimental Pathology62:519–525.

    PubMed  Google Scholar 

  11. Hellerqvist, C. G., Rojas, J., Green, R. S., Sell, S., Sundell, H., Stahlman, M. T. 1981. Studies on group B β-hemolytic streptococcus. I. Isolation and partial characterization of an extracellular toxin. Pediatric Research15:892–898.

    PubMed  Google Scholar 

  12. Holder, I. A., Haidaris, C. F. 1979. Experimental studies of the pathogenesis of infections due toPseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors. Canadian Journal of Microbiology25:593–599.

    PubMed  Google Scholar 

  13. Kaijser, B., Ahlstedt, S. 1977. Protective capacity of antibodies againstEscherichia coli O and K antigens. Infection and Immunity17:286–289.

    PubMed  Google Scholar 

  14. Kasper, D. L., Baker, C. J. 1979. Electron microscopic definition of surface antigens of group B streptococcus. Journal of Infectious Diseases139:147–151.

    PubMed  Google Scholar 

  15. Kelly, R. T., Freiff, D., Farmer, S. 1966. Neuraminidase activity inDiplococcus pneumoniae. Journal of Bacteriology91:601–603.

    Google Scholar 

  16. Kjems, E., Perch, B., Henrichsen, J. 1980. Serotypes of group B streptococci and their relation to hyaluronidase production and hydrolysis of salicin. Journal of Clinical Microbiology11:111–113.

    PubMed  Google Scholar 

  17. Milligan, T. W., Baker, C. J., Straus, D. C., Mattingly, S. J. 1978. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infection and Immunity21:738–746.

    PubMed  Google Scholar 

  18. Milligan, T. W., Doran, T. I., Straus, D. C., Mattingly, S. J. 1978. Growth and amino acid requirements of various strains of group B streptococci. Journal of Clinical Microbiology7:28–33.

    PubMed  Google Scholar 

  19. Milligan, T. W., Mattingly, S. J., Straus, D. C. 1980. Purification and partial characterization of neuraminidase from type III group B streptococci. Journal of Bacteriology144:164–172.

    PubMed  Google Scholar 

  20. Milligan, T. W., Straus, D. C., Mattingly, S. J. 1977. Extracellular neuraminidase production by group B streptococci. Infection and Immunity18:189–195.

    PubMed  Google Scholar 

  21. Pavlovskis, O. R., Wretlind, B. 1979. Assessment of protease (elastase) as aPseudomonas aeruginosa virulence factor in experimental mouse burn infection. Infection and Immunity24:181–187.

    PubMed  Google Scholar 

  22. Pollack, M. 1976. Significance of circulating capsular antigen in Klebsiella infections. Infection and Immunity13:1543–1548.

    Google Scholar 

  23. Reed, L. J., Muench, H. A. 1938. A simple method of estimating fifty percent endpoints. American Journal of Hygiene27:493–497.

    Google Scholar 

  24. Straus, D. C., Mattingly, S. J., Milligan, T. W., Doran, T. I., Nealon, T. J. 1980. Protease production by clinical isolates of type III group B streptococci. Journal of Clinical Microbiology12:421–425.

    PubMed  Google Scholar 

  25. Todd, E. W. 1934. A comparative serological study of streptolysins derived from human and from animal infections with notes on pneumococcal hemolysin, tetanolysin, and staphylococcus toxin. Journal of Pathological Bacteriology39:299–321.

    Google Scholar 

  26. Weller, P. F., Smith, A. L., Anderson, P., Smith, D. H. 1977. The role of encapsulation and host age in the clearance ofHaemophilus influenzae bacteremia. Journal of Infectious Diseases135:34–41.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, The University of Texas Health Science Center at San Antonio, 78284, San Antonio, Texas

    David L. Durham

  2. Department of Microbiology, Texas Tech University Health Sciences Center, 79430, Lubbock, Texas

    David C. Straus

Authors
  1. David L. Durham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David C. Straus
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Durham, D.L., Straus, D.C. Extracellular products of type IIIStreptococcus agalactiae and their relationship to virulence. Current Microbiology 8, 89–94 (1983). https://doi.org/10.1007/BF01566964

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01566964

Keywords

Search

Navigation